July 25, 2024 — In a rigorous medical records study covering tens of thousands of patients, researchers conclude that some patients with preoperative anemia have better outcomes if they get iron ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug ...

Jan. 28, 2025 — Calorie labels on restaurant menus are negatively impacting people with eating disorders, according to a new study. The review found that individuals who have been diagnosed with ...

The U.S. Food and Drug Administration has approved Susvimo (ranibizumab) 100 mg/mL for treating diabetic macular edema.

jsiec.org Purpose To determine the prevalence and risk factors for diabetic retinopathy (DR) and sight-threatening diabetic retinopathy (STDR) in a multi-hospital-based DR screening programme among ...

[49] There are various safety issues to consider: immunogenicity, teratogenicity and embryotoxicity, and retinopathy. Teratogenicity and embryotoxicity: studies on experimental animals have not ...

Many drugs are being administered to tackle coronavirus disease 2019 (COVID-19) pandemic situations without establishing clinical effectiveness or tailoring safety. A repurposing strategy might be ...

FDA Approves Genentech’s Susvimo as the First and Only Continuous Delivery Treatment for the Leading Cause of Diabetes-Related Blindness – Susvimo is the first and only continuous delivery ...

Diabetes mellitus is one of the most common medical complications of pregnancy; gestational diabetes mellitus (GDM) accounts for approximately 90-95% of all cases. GDM is defined as carbohydrate ...